102 related articles for article (PubMed ID: 12235240)
1. Peptide antagonists of ethanol inhibition of l1-mediated cell-cell adhesion.
Wilkemeyer MF; Menkari CE; Spong CY; Charness ME
J Pharmacol Exp Ther; 2002 Oct; 303(1):110-6. PubMed ID: 12235240
[TBL] [Abstract][Full Text] [Related]
2. Ethanol antagonist peptides: structural specificity without stereospecificity.
Wilkemeyer MF; Chen SY; Menkari CE; Sulik KK; Charness ME
J Pharmacol Exp Ther; 2004 Jun; 309(3):1183-9. PubMed ID: 14762101
[TBL] [Abstract][Full Text] [Related]
3. Synergistic effects of the peptide fragment D-NAPVSIPQ on ethanol inhibition of synaptic plasticity and NMDA receptors in rat hippocampus.
Zhang TA; Hendricson AW; Wilkemeyer MF; Lippmann MJ; Charness ME; Morrisett RA
Neuroscience; 2005; 134(2):583-93. PubMed ID: 15963648
[TBL] [Abstract][Full Text] [Related]
4. Peptide-mediated protection from ethanol-induced neural tube defects.
Chen SY; Charness ME; Wilkemeyer MF; Sulik KK
Dev Neurosci; 2005; 27(1):13-9. PubMed ID: 15886480
[TBL] [Abstract][Full Text] [Related]
5. Alcohol inhibition of cell adhesion in BMP-treated NG108-15 cells.
Wilkemeyer MF; Pajerski M; Charness ME
Alcohol Clin Exp Res; 1999 Nov; 23(11):1711-20. PubMed ID: 10591586
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective Peptide NAPVSIPQ Antagonizes Ethanol Inhibition of L1 Adhesion by Promoting the Dissociation of L1 and Ankyrin-G.
Dou X; Lee JY; Charness ME
Biol Psychiatry; 2020 Apr; 87(7):656-665. PubMed ID: 31640849
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of ethanol antagonism and neuroprotection in peptide fragment NAPVSIPQ prevention of ethanol-induced developmental toxicity.
Wilkemeyer MF; Chen SY; Menkari CE; Brenneman DE; Sulik KK; Charness ME
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8543-8. PubMed ID: 12808140
[TBL] [Abstract][Full Text] [Related]
8. Novel antagonists of alcohol inhibition of l1-mediated cell adhesion: multiple mechanisms of action.
Wilkemeyer MF; Menkari CE; Charness ME
Mol Pharmacol; 2002 Nov; 62(5):1053-60. PubMed ID: 12391267
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective peptides influence cytokine and chemokine alterations in a model of fetal alcohol syndrome.
Roberson R; Kuddo T; Benassou I; Abebe D; Spong CY
Am J Obstet Gynecol; 2012 Dec; 207(6):499.e1-5. PubMed ID: 23174390
[TBL] [Abstract][Full Text] [Related]
10. NAP, a peptide derived from the activity-dependent neuroprotective protein, modulates macrophage function.
Quintana FJ; Zaltzman R; Fernandez-Montesinos R; Herrera JL; Gozes I; Cohen IR; Pozo D
Ann N Y Acad Sci; 2006 Jul; 1070():500-6. PubMed ID: 16888216
[TBL] [Abstract][Full Text] [Related]
11. Effects of ethanol and NAP on cerebellar expression of the neural cell adhesion molecule L1.
Fitzgerald DM; Charness ME; Leite-Morris KA; Chen S
PLoS One; 2011; 6(9):e24364. PubMed ID: 21931691
[TBL] [Abstract][Full Text] [Related]
12. Alcohol inhibits cell-cell adhesion mediated by human L1.
Ramanathan R; Wilkemeyer MF; Mittal B; Perides G; Charness ME
J Cell Biol; 1996 Apr; 133(2):381-90. PubMed ID: 8609170
[TBL] [Abstract][Full Text] [Related]
13. D-SAL and NAP: Two Peptides Sharing a SIP Domain.
Gozes I; Sragovich S; Schirer Y; Idan-Feldman A
J Mol Neurosci; 2016 Jun; 59(2):220-31. PubMed ID: 26816081
[TBL] [Abstract][Full Text] [Related]
14. NAP protects hippocampal neurons against multiple toxins.
Zemlyak I; Manley N; Sapolsky R; Gozes I
Peptides; 2007 Oct; 28(10):2004-8. PubMed ID: 17869381
[TBL] [Abstract][Full Text] [Related]
15. Protection against tauopathy by the drug candidates NAP (davunetide) and D-SAL: biochemical, cellular and behavioral aspects.
Shiryaev N; Pikman R; Giladi E; Gozes I
Curr Pharm Des; 2011; 17(25):2603-12. PubMed ID: 21728979
[TBL] [Abstract][Full Text] [Related]
16. Role of versican and hyaluronan in the differentiation of 3T3-L1 cells into preadipocytes and mature adipocytes.
Zizola CF; Julianelli V; Bertolesi G; Yanagishita M; Calvo JC
Matrix Biol; 2007 Jul; 26(6):419-30. PubMed ID: 17513099
[TBL] [Abstract][Full Text] [Related]
17. Protective peptides that are orally active and mechanistically nonchiral.
Brenneman DE; Spong CY; Hauser JM; Abebe D; Pinhasov A; Golian T; Gozes I
J Pharmacol Exp Ther; 2004 Jun; 309(3):1190-7. PubMed ID: 15007105
[TBL] [Abstract][Full Text] [Related]
18. Learning enhancement with neuropeptides.
Toso L; Endres M; Vink J; Abebe DT; Brenneman DE; Spong CY
Am J Obstet Gynecol; 2006 Apr; 194(4):1153-8; discussion 1158-9. PubMed ID: 16580319
[TBL] [Abstract][Full Text] [Related]
19. Effect of lipid raft disruption on ethanol inhibition of l1 adhesion.
Dou X; Charness ME
Alcohol Clin Exp Res; 2014 Nov; 38(11):2707-11. PubMed ID: 25421507
[TBL] [Abstract][Full Text] [Related]
20. L1 coupling to ankyrin and the spectrin-actin cytoskeleton modulates ethanol inhibition of L1 adhesion and ethanol teratogenesis.
Dou X; Menkari C; Mitsuyama R; Foroud T; Wetherill L; Hammond P; Suttie M; Chen X; Chen SY; Charness ME;
FASEB J; 2018 Mar; 32(3):1364-1374. PubMed ID: 29109170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
